George Washington University, Milken Institute School of Public Health, Washington, DC.
National Bureau of Economics Research, Cambridge, MA.
Med Care. 2024 Aug 1;62(8):521-529. doi: 10.1097/MLR.0000000000002028. Epub 2024 Jun 12.
Recent efforts to increase access to kidney transplant (KTx) in the United States include increasing referrals to transplant programs, leading to more pretransplant services. Transplant programs reconcile the costs of these services through the Organ Acquisition Cost Center (OACC).
The aim of this study was to determine the costs associated with pretransplant services by applying microeconomic methods to OACC costs reported by transplant hospitals.
RESEARCH DESIGN, SUBJECTS, AND MEASURES: For all US adult kidney transplant hospitals from 2013 through 2018 (n=193), we crosslinked the total OACC costs (at the hospital-fiscal year level) to proxy measures of volumes of pretransplant services. We used a multiple-output cost function, regressing total OACC costs against proxy measures for volumes of pretransplant services and adjusting for patient characteristics, to calculate the marginal cost of each pretransplant service.
Over 1015 adult hospital-years, median OACC costs attributable to the pretransplant services were $5 million. Marginal costs for the pretransplant services were: initial transplant evaluation, $9k per waitlist addition; waitlist management, $2k per patient-year on the waitlist; deceased donor offer management, $1k per offer; living donor evaluation, procurement and follow-up: $26k per living donor. Longer time on dialysis among patients added to the waitlist was associated with higher OACC costs at the transplant hospital.
To achieve the policy goals of more access to KTx, sufficient funding is needed to support the increase in volume of pretransplant services. Future studies should assess the relative value of each service and explore ways to enhance efficiency.
最近,美国为增加肾移植 (KTx) 的可及性做出了诸多努力,包括增加向移植项目的转诊,从而增加了移植前服务。移植项目通过器官获取成本中心 (OACC) 来平衡这些服务的成本。
本研究旨在通过将移植医院报告的 OACC 成本应用于微观经济方法来确定与移植前服务相关的成本。
研究设计、对象和方法:对 2013 年至 2018 年所有美国成人肾移植医院(n=193),我们将总 OACC 成本(在医院-财政年度水平)与移植前服务量的代理指标进行交叉链接。我们使用多产出成本函数,将总 OACC 成本与移植前服务量的代理指标进行回归,并根据患者特征进行调整,以计算每项移植前服务的边际成本。
在超过 1015 个成人医院年中,归因于移植前服务的 OACC 中位数成本为 500 万美元。移植前服务的边际成本分别为:初始移植评估,每增加一个等待名单患者 9000 美元;等待名单管理,每位等待名单上的患者每年 2000 美元;已故供体提供管理,每份提供 1000 美元;活体供体评估、采购和随访:每位活体供体 26000 美元。等待名单上的患者透析时间延长与移植医院的 OACC 成本增加有关。
为了实现更多获得 KTx 的政策目标,需要有足够的资金来支持移植前服务量的增加。未来的研究应该评估每项服务的相对价值,并探索提高效率的方法。